Abstract
There is accumulating evidence from randomized trials suggesting that digital patient-centered care allows a more reliable detection of tumour-related symptoms and adverse events – with a direct impact on overall survival. Consequently, a variety of unsynchronized approaches were kicked off to (electronically) measure patient-reported outcomes (PROs). Despite increasing evidence that PRO data are highly relevant for patient care, the data generated in these initial projects lack standardized processing pathways in order to impact clinical routine; therefore, potential future routine PRO assessments require adequate analysis, storage and processing to allow a robust, reproducible and reliable incorporation into routine clinical decision-making. Here, we discuss relevant challenges of digital follow-up that need to be tackled to render PRO data as relevant to physicians as laboratory or biomarker data.
References
1.
Corrigan
J
. Building a Better Delivery System: A New Engineering/Health Care Partnership. In: Press
NA
, editor. IOM (Institute of Medicine)
. 2001
.2.
Sood
S
, Mbarika
V
, Jugoo
S
, Dookhy
R
, Doarn
CR
, Prakash
N
, et al. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings
. Telemed J E Health
. 2007
Oct
;13
(5
):573
–90
.
[PubMed]
1530-56273.
Korzilius
H
. Hausärztemangel in Deutschland: die große Landflucht
. Dtsch Arztebl Int
. 2008
;105
:A-373
.1866-04524.
Denis
F
, Lethrosne
C
, Pourel
N
, Molinier
O
, Pointreau
Y
, Domont
J
, et al. Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients
. J Natl Cancer Inst
. 2017
Sep
;109
(9
):109
.
[PubMed]
0027-88745.
Orlov
OI
, Drozdov
DV
, Doarn
CR
, Merrell
RC
. Wireless ECG monitoring by telephone
. Telemed J E Health
. 2001
;7
(1
):33
–8
.
[PubMed]
1530-56276.
Tachakra
S
, Wang
XH
, Istepanian
RS
, Song
YH
. Mobile e-health: the unwired evolution of telemedicine
. Telemed J E Health
. 2003
;9
(3
):247
–57
.
[PubMed]
1530-56277.
Zhao
X
, Fei
DY
, Doarn
CR
, Harnett
B
, Merrell
R
. A telemedicine system for wireless home healthcare based on Bluetooth and the Internet
. Telemed J E Health
. 2004
;10
(1
Suppl 2
):S-110
–6
.
[PubMed]
1530-56278.
Basch
E
, Deal
AM
, Kris
MG
, Scher
HI
, Hudis
CA
, Sabbatini
P
, et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
. J Clin Oncol
. 2016
Feb
;34
(6
):557
–65
.
[PubMed]
0732-183X9.
Vodicka
E
, Kim
K
, Devine
EB
, Gnanasakthy
A
, Scoggins
JF
, Patrick
DL
. Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007-2013)
. Contemp Clin Trials
. 2015
Jul
;43
:1
–9
.
[PubMed]
1551-714410.
Bottomley
A
, Pe
M
, Sloan
J
, Basch
E
, Bonnetain
F
, Calvert
M
, et al.; Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) consortium
. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
. Lancet Oncol
. 2016
Nov
;17
(11
):e510
–4
.
[PubMed]
1470-204511.
Basch
E
, Deal
AM
, Dueck
AC
, Scher
HI
, Kris
MG
, Hudis
C
, et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
. JAMA
. 2017
Jul
;318
(2
):197
–8
.
[PubMed]
0098-748412.
Basch
E
, Reeve
BB
, Mitchell
SA
, Clauser
SB
, Minasian
LM
, Dueck
AC
, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
. J Natl Cancer Inst
. 2014
Sep
;106
(9
):106
.
[PubMed]
0027-887413.
FDA-NIH Biomarker Working Group
. (2016
). BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]. Silver Spring, MD: US Food and Drug Administration; https://www.ncbi.nlm.nih.gov/books/NBK326791/pdf/Bookshelf_NBK326791.pdf14.
Mokkink
LB
, Terwee
CB
, Patrick
DL
, Alonso
J
, Stratford
PW
, Knol
DL
, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes
. J Clin Epidemiol
. 2010
Jul
;63
(7
):737
–45
.
[PubMed]
0895-435615.
Kaasa
S
, Bjordal
K
, Aaronson
N
, Moum
T
, Wist
E
, Hagen
S
, et al. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy
. Eur J Cancer
. 1995
Dec
;31A
(13-14
):2260
–3
.
[PubMed]
0959-804916.
Hjermstad
MJ
, Fossa
SD
, Bjordal
K
, Kaasa
S
. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire
. J Clin Oncol
. 1995
May
;13
(5
):1249
–54
.
[PubMed]
0732-183X17.
Smets
EM
, Visser
MR
, Willems-Groot
AF
, Garssen
B
, Schuster-Uitterhoeve
AL
, de Haes
JC
. Fatigue and radiotherapy: (B) experience in patients 9 months following treatment
. Br J Cancer
. 1998
Oct
;78
(7
):907
–12
.
[PubMed]
0007-092018.
Basch
E
, Abernethy
AP
. Supporting clinical practice decisions with real-time patient-reported outcomes
. J Clin Oncol
. 2011
Mar
;29
(8
):954
–6
.
[PubMed]
0732-183X19.
Gotay
CC
, Kawamoto
CT
, Bottomley
A
, Efficace
F
. The prognostic significance of patient-reported outcomes in cancer clinical trials
. J Clin Oncol
. 2008
Mar
;26
(8
):1355
–63
.
[PubMed]
0732-183X20.
Quinten
C
, Coens
C
, Mauer
M
, Comte
S
, Sprangers
MA
, Cleeland
C
, et al.; EORTC Clinical Groups
. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
. Lancet Oncol
. 2009
Sep
;10
(9
):865
–71
.
[PubMed]
1470-204521.
Fromme
EK
, Eilers
KM
, Mori
M
, Hsieh
YC
, Beer
TM
. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30
. J Clin Oncol
. 2004
Sep
;22
(17
):3485
–90
.
[PubMed]
0732-183X22.
Testa
MA
, Anderson
RB
, Nackley
JF
, Hollenberg
NK
; The Quality-of-Life Hypertension Study Group
. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril
. N Engl J Med
. 1993
Apr
;328
(13
):907
–13
.
[PubMed]
0028-479323.
Denis
F
, Viger
L
, Charron
A
, Voog
E
, Letellier
C
. Detecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up
. Support Care Cancer
. 2014
Jan
;22
(1
):79
–85
.
[PubMed]
0941-435524.
Kessel
KA
, Vogel
MM
, Schmidt-Graf
F
, Combs
SE
. Mobile Apps in Oncology: A Survey on Health Care Professionals’ Attitude Toward Telemedicine, mHealth, and Oncological Apps
. J Med Internet Res
. 2016
Nov
;18
(11
):e312
.
[PubMed]
1438-887125.
Kessel
KA
, Vogel
MM
, Kessel
C
, Bier
H
, Biedermann
T
, Friess
H
, et al. Mobile Health in Oncology: A Patient Survey About App-Assisted Cancer Care
. JMIR Mhealth Uhealth
. 2017
Jun
;5
(6
):e81
.
[PubMed]
2291-522226.
El Shafie
RA
, Weber
D
, Bougatf
N
, Sprave
T
, Oetzel
D
, Huber
PE
, et al. Supportive Care in Radiotherapy Based on a Mobile App: Prospective Multicenter Survey
. JMIR Mhealth Uhealth
. 2018
Aug
;6
(8
):e10916
.
[PubMed]
2291-522227.
Min
YH
, Lee
JW
, Shin
YW
, Jo
MW
, Sohn
G
, Lee
JH
, et al. Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study
. J Med Internet Res
. 2014
May
;16
(5
):e135
.
[PubMed]
1438-887128.
Stinson
JN
, Jibb
LA
, Nguyen
C
, Nathan
PC
, Maloney
AM
, Dupuis
LL
, et al. Development and testing of a multidimensional iPhone pain assessment application for adolescents with cancer
. J Med Internet Res
. 2013
Mar
;15
(3
):e51
.
[PubMed]
1438-887129.
Benze
G
, Nauck
F
, Alt-Epping
B
, Gianni
G
, Bauknecht
T
, Ettl
J
, et al. PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer
. Ann Palliat Med
. 2017
Oct
;6
:apm.2017.07.05
.
[PubMed]
2224-582030.
El Shafie
RA
, Bougatf
N
, Sprave
T
, Weber
D
, Oetzel
D
, Machmer
T
, et al. Oncologic Therapy Support Via Means of a Dedicated Mobile App (OPTIMISE-1): Protocol for a Prospective Pilot Trial
. JMIR Res Protoc
. 2018
Mar
;7
(3
):e70
.
[PubMed]
1929-074831.
Theile
G
, Klaas
V
, Tröster
G
, Guckenberger
M
. mHealth Technologies for Palliative Care Patients at the Interface of In-Patient to Outpatient Care: Protocol of Feasibility Study Aiming to Early Predict Deterioration of Patient’s Health Status
. JMIR Res Protoc
. 2017
Aug
;6
(8
):e142
.
[PubMed]
1929-074832.
Stone
AA
, Shiffman
S
, Schwartz
JE
, Broderick
JE
, Hufford
MR
. Patient non-compliance with paper diaries
. BMJ
. 2002
May
;324
(7347
):1193
–4
.
[PubMed]
0959-813833.
Appelboom
G
, Camacho
E
, Abraham
ME
, Bruce
SS
, Dumont
EL
, Zacharia
BE
, et al. Smart wearable body sensors for patient self-assessment and monitoring
. Arch Public Health
. 2014
Aug
;72
(1
):28
.
[PubMed]
0778-736734.
Rahman
QA
, Janmohamed
T
, Pirbaglou
M
, Ritvo
P
, Heffernan
JM
, Clarke
H
, et al. Patterns of User Engagement With the Mobile App, Manage My Pain: Results of a Data Mining Investigation
. JMIR Mhealth Uhealth
. 2017
Jul
;5
(7
):e96
.
[PubMed]
2291-522235.
Peltola
MK
, Lehikoinen
JS
, Sippola
LT
, Saarilahti
K
, Mäkitie
AA
. A Novel Digital Patient-Reported Outcome Platform for Head and Neck Oncology Patients-A Pilot Study
. Clin Med Insights Ear Nose Throat
. 2016
Sep
;9
:1
–6
.
[PubMed]
1179-550636.
Gwaltney
CJ
, Shields
AL
, Shiffman
S
. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review
. Value Health
. 2008
Mar-Apr
;11
(2
):322
–33
.
[PubMed]
1098-301537.
Garg
AX
, Adhikari
NK
, McDonald
H
, Rosas-Arellano
MP
, Devereaux
PJ
, Beyene
J
, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review
. JAMA
. 2005
Mar
;293
(10
):1223
–38
.
[PubMed]
0098-748438.
Kawamoto
K
, Houlihan
CA
, Balas
EA
, Lobach
DF
. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success
. BMJ
. 2005
Apr
;330
(7494
):765
.
[PubMed]
0959-813839.
Calvert
M
, Kyte
D
, Duffy
H
, Gheorghe
A
, Mercieca-Bebber
R
, Ives
J
, et al. Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writers
. PLoS One
. 2014
Oct
;9
(10
):e110216
.
[PubMed]
1932-620340.
Calvert
M
, Blazeby
J
, Altman
DG
, Revicki
DA
, Moher
D
, Brundage
MD
, et al.; CONSORT PRO Group
. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension
. JAMA
. 2013
Feb
;309
(8
):814
–22
.
[PubMed]
0098-748441.
Turner
L
, Shamseer
L
, Altman
DG
, Weeks
L
, Peters
J
, Kober
T
, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals
. Cochrane Database Syst Rev
. 2012
Nov
;11
:MR000030
.
[PubMed]
1469-493X42.
Garcia
SF
, Cella
D
, Clauser
SB
, Flynn
KE
, Lad
T
, Lai
JS
, et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative
. J Clin Oncol
. 2007
Nov
;25
(32
):5106
–12
.
[PubMed]
0732-183X© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
